Imaging of Metabolic Bone Diseases: The Spine View, Part I

Abstract

Metabolic bone diseases comprise a wide spectrum. Of them, osteoporosis is the most frequent and the most commonly found in the spine, with a high impact on health care systems and on morbidity due to vertebral fractures (VFs).

This article discusses state-of-the-art techniques on the imaging of metabolic bone diseases in the spine, from the well-established methods to the latest improvements, recent developments, and future perspectives.

We review the classical features of involvement of metabolic conditions involving the spine. Then we analyze the different imaging techniques for the diagnosis, characterization, and monitoring of metabolic bone disease: dual-energy X-ray absorptiometry (DXA) and DXA-based fracture risk assessment applications or indexes, such as the geometric parameters, Bone Strain Index, and Trabecular Bone Score; quantitative computed tomography; and magnetic resonance and ultrasonography-based techniques, such as radiofrequency echographic multi spectrometry. We also describe the current possibilities of imaging to guide the treatment of VFs secondary to metabolic bone disease.

Keywords

osteoporosis - vertebral fractures - dual-energy X-ray absorptiometry - quantitative computed tomography - radiofrequency echographic multi spectrometry

Publication History

Article published online:
14 September 2022

• References

• 1 Kanis JA, McCloskey EV, Johansson H, Cooper C, Rizzoli R, Reginster JY. Scientific Advisory Board of the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO) and the Committee of Scientific Advisors of the International Osteoporosis Foundation (IOF). European guidance for the diagnosis and management of osteoporosis in postmenopausal women. Osteoporos Int 2013; 24 (01) 23-57
• 2 Hernlund E, Svedbom A, Ivergård M. et al. Osteoporosis in the European Union: medical management, epidemiology and economic burden. A report prepared in collaboration with the International Osteoporosis Foundation (IOF) and the European Federation of Pharmaceutical Industry Associations (EFPIA). Arch Osteoporos 2013; 8 (1–2): 136
• 3 Guglielmi G, Muscarella S, Bazzocchi A. Integrated imaging approach to osteoporosis: state-of-the-art review and update. Radiographics 2011; 31 (05) 1343-1364
• 4 Cauley JA, Hochberg MC, Lui LY. et al. Long-term risk of incident vertebral fractures. JAMA 2007; 298 (23) 2761-2767
• 5 Bennett J, Suliburk JW, Morón FE. Osseous manifestations of primary hyperparathyroidism: imaging findings. Int J Endocrinol 2020; 2020: 3146535
• 6 Murphey MD, Sartoris DJ, Quale JL, Pathria MN, Martin NL. Musculoskeletal manifestations of chronic renal insufficiency. Radiographics 1993; 13 (02) 357-379
• 7 Theodorou DJ, Theodorou SJ, Kakitsubata Y. Imaging of Paget disease of bone and its musculoskeletal complications: review. AJR Am J Roentgenol 2011; 196 (6, Suppl): S64-S75
• 8 Aparisi Gómez MP, Trisolino G, Sangiorgi L, Guglielmi G, Bazzocchi A. Imaging of congenital skeletal disorders. Semin Musculoskelet Radiol 2021; 25 (01) 22-38
• 9 Chang CY, Rosenthal DI, Mitchell DM, Handa A, Kattapuram SV, Huang AJ. Imaging findings of metabolic bone disease. Radiographics 2016; 36 (06) 1871-1887
• 10 Messina C, Sconfienza LM, Bandirali M, Guglielmi G, Ulivieri FM. Adult dual-energy X-ray absorptiometry in clinical practice: how I report it. Semin Musculoskelet Radiol 2016; 20 (03) 246-253
• 11 Silva BC, Broy SB, Boutroy S, Schousboe JT, Shepherd JA, Leslie WD. Fracture risk prediction by non-BMD DXA measures: the 2015 ISCD official positions Part 2: Trabecular bone score. J Clin Densitom 2015; 18 (03) 309-330
• 12 Broy SB, Cauley JA, Lewiecki ME, Schousboe JT, Shepherd JA, Leslie WD. Fracture risk prediction by non-BMD DXA measures: the 2015 ISCD official positions Part 1: Hip geometry. J Clin Densitom 2015; 18 (03) 287-308
• 13 Ulivieri FM, Rinaudo L. Beyond bone mineral density: a new dual X-ray absorptiometry index of bone strength to predict fragility fractures, the Bone Strain Index. Front Med (Lausanne) 2021; 7: 590139
• 14 Messina C, Rinaudo L, Cesana BM. et al. Prediction of osteoporotic fragility re-fracture with lumbar spine DXA-based derived bone strain index: a multicenter validation study. Osteoporos Int 2021; 32 (01) 85-91
• 15 Tabacco G, Naciu AM, Messina C. et al. DXA-based Bone Strain Index: a new tool to evaluate bone quality in primary hyperparathyroidism. J Clin Endocrinol Metab 2021; 106 (08) 2304-2312
• 16 McCloskey EV, Odén A, Harvey NC. et al. A meta-analysis of trabecular bone score in fracture risk prediction and its relationship to FRAX. J Bone Miner Res 2016; 31 (05) 940-948
• 17 Bandirali M, Poloni A, Sconfienza LM. et al. Short-term precision assessment of trabecular bone score and bone mineral density using dual-energy X-ray absorptiometry with different scan modes: an in vivo study. Eur Radiol 2015; 25 (07) 2194-2198
• 18 Krohn K, Schwartz EN, Chung YS, Lewiecki EM. Dual-energy X-ray absorptiometry monitoring with Trabecular Bone Score: 2019 ISCD official position. J Clin Densitom 2019; 22 (04) 501-505
• 19 Li N, Li XM, Xu L, Sun WJ, Cheng XG, Tian W. Comparison of QCT and DXA: osteoporosis detection rates in postmenopausal women. Int J Endocrinol 2013; 2013: 895474
• 20 Adams JE. Quantitative computed tomography. Eur J Radiol 2009; 71 (03) 415-424
• 21 Shuhart CR, Yeap SS, Anderson PA. et al. Executive summary of the 2019 ISCD Position Development Conference on Monitoring Treatment, DXA Cross-calibration and Least Significant Change, Spinal Cord Injury, Peri-prosthetic and Orthopedic Bone Health, Transgender Medicine, and Pediatrics. J Clin Densitom 2019; 22 (04) 453-471
• 22 Yu W, Glüer CC, Grampp S. et al. Spinal bone mineral assessment in postmenopausal women: a comparison between dual X-ray absorptiometry and quantitative computed tomography. Osteoporos Int 1995; 5 (06) 433-439
• 23 Engelke K, Adams JE, Armbrecht G. et al. Clinical use of quantitative computed tomography and peripheral quantitative computed tomography in the management of osteoporosis in adults: the 2007 ISCD Official Positions. J Clin Densitom 2008; 11 (01) 123-162
• 24 Lang TF, Li J, Harris ST, Genant HK. Assessment of vertebral bone mineral density using volumetric quantitative CT. J Comput Assist Tomogr 1999; 23 (01) 130-137
• 25 Krug R, Carballido-Gamio J, Burghardt AJ. et al. Assessment of trabecular bone structure comparing magnetic resonance imaging at 3 Tesla with high-resolution peripheral quantitative computed tomography ex vivo and in vivo. Osteoporos Int 2008; 19 (05) 653-661
• 26 Krug R, Stehling C, Kelley DAC, Majumdar S, Link TM. Imaging of the musculoskeletal system in vivo using ultra-high field magnetic resonance at 7 T. Invest Radiol 2009; 44 (09) 613-618
• 27 Krug R, Burghardt AJ, Majumdar S, Link TM. High-resolution imaging techniques for the assessment of osteoporosis. Radiol Clin North Am 2010; 48 (03) 601-621
• 28 Fazeli PK, Horowitz MC, MacDougald OA. et al. Marrow fat and bone—new perspectives. J Clin Endocrinol Metab 2013; 98 (03) 935-945
• 29 Soldati E, Rossi F, Vicente J. et al. Survey of MRI usefulness for the clinical assessment of bone microstructure. Int J Mol Sci 2021; 22 (05) 2509
• 30 Bandirali M, Di Leo G, Papini GDE. et al. A new diagnostic score to detect osteoporosis in patients undergoing lumbar spine MRI. Eur Radiol 2015; 25 (10) 2951-2959
• 31 Ehresman J, Schilling A, Yang X. et al. Vertebral bone quality score predicts fragility fractures independently of bone mineral density. Spine J 2021; 21 (01) 20-27
• 32 Caffarelli C, Tomai Pitinca MD, Al Refaie A, Ceccarelli E, Gonnelli S. Ability of radiofrequency echographic multispectrometry to identify osteoporosis status in elderly women with type 2 diabetes. Aging Clin Exp Res 2022; 34 (01) 121-127
• 33 Diez-Perez A, Brandi ML, Al-Daghri N. et al. Radiofrequency echographic multi-spectrometry for the in-vivo assessment of bone strength: state of the art-outcomes of an expert consensus meeting organized by the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO). Aging Clin Exp Res 2019; 31 (10) 1375-1389
• 34 Wang CY, Chu SY, Lin YC. et al. Quantitative imaging of ultrasound backscattered signals with information entropy for bone microstructure characterization. Sci Rep 2022; 12 (01) 414
• 35 Cho S, Park HS, Kim DY, Kim CH, Chung RK, Kim YJ. Percutaneous sacroplasty under fluoroscopic guidance combined with epidurogram for sacral insufficiency fracture resulting from metastatic tumor and osteoporosis. Pain Physician 2016; 19 (03) E473-E480
• 36 Tsoumakidou G, Too CW, Koch G. et al. CIRSE guidelines on percutaneous vertebral augmentation. Cardiovasc Intervent Radiol 2017; 40 (03) 331-342
• 37 Vanni D, Pantalone A, Magliani V, Salini V, Berjano P. Corpectomy and expandable cage replacement versus third generation percutaneous augmentation system in case of vertebra plana: rationale and recommendations. J Spine Surg 2017; 3 (03) 379-386
• 38 Yang JS, Zou P, Chai X, Li QD, Zhao YT, Hao DJ. In response to RE: “Can Additional Facet Joint Block Improve the Clinical Outcome of Kyphoplasty for Acute Osteoporotic Vertebral Compression Fractures?”. Pain Physician 2021; 24 (06) E898
• 39 Klazen CAH, Lohle PNM, de Vries J. et al. Vertebroplasty versus conservative treatment in acute osteoporotic vertebral compression fractures (Vertos II): an open-label randomised trial. Lancet 2010; 376 (9746): 1085-1092
• 40 McConnell Jr CT, Wippold II FJ, Ray Jr CE. et al. ACR appropriateness criteria management of vertebral compression fractures. J Am Coll Radiol 2014; 11 (08) 757-763